Salix reports November 6

• Salix Pharmaceuticals (NASDAQ:SLXP +0.3%) will report Q3 results on November 6 after the close. The conference call will begin at 4:30 pm ET.
• Consensus view is EPS of $1.56 on revenues of $395M.